AR ChIP-seq differential binding analysis yielded HOXB13 motif as selectively enriched in resistant tissue, suggesting a role of HOXB13 in resistant prostate cancer as found by others (Jeong et al, 2012). Here, HOXB13 is linked to prostate carcinoma.